Sarepta Therapeutics, Inc.
SRPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $235 | -$536 | -$703 | -$419 |
| Dep. & Amort. | $38 | $44 | $42 | $38 |
| Deferred Tax | $0 | $0 | $0 | $16 |
| Stock-Based Comp. | $184 | $183 | $233 | $114 |
| Change in WC | -$717 | -$481 | -$39 | -$98 |
| Other Non-Cash | $54 | $289 | $143 | -$94 |
| Operating Cash Flow | -$206 | -$501 | -$325 | -$443 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$137 | -$76 | -$31 | -$38 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,100 | -$2,049 | -$1,938 | -$30 |
| Inv. Sales/Matur. | $2,002 | $1,868 | $923 | $466 |
| Other Inv. Act. | -$10 | $91 | -$1 | $98 |
| Investing Cash Flow | $756 | -$166 | -$1,047 | $495 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $0 | $304 | $0 |
| Stock Issued | $80 | $0 | $0 | $549 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $45 | $125 | -$72 | $13 |
| Financing Cash Flow | $125 | $125 | $233 | $562 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $675 | -$542 | -$1,140 | $614 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $444 | $986 | $2,126 | $1,512 |
| End Cash | $1,119 | $444 | $986 | $2,126 |
| Free Cash Flow | -$343 | -$588 | -$358 | -$482 |